Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NADMED Ltd. logo — The standard of NAD measuring.

NADMED Ltd.

The standard of NAD measuring.

Founded 2022 Finland Finland 20 employees Seed Total: $3.50M Biotechnology

General Information

Company Name NADMED Ltd.
Founded Year 2022
Location Finland Finland +1
Employees 20
Industries Biotechnology
Funding Stage Seed
Social

Get notified when NADMED Ltd. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NADMED Ltd.

NADMED Ltd., founded in 2022, is a biotechnology startup based in Finland. The company has rapidly made a name for itself in the industry with its innovative approach to measuring NADs from whole blood and other sample matrices. With the slogan, "The standard of NAD measuring," NADMED Oy has introduced a high-throughput method that stands out for its accuracy and potential to revolutionize diagnostics.

The company recently secured a $3.50M grant investment on 01 August 2024 from notable investors including Voima Ventures, University of Helsinki, and Nordic Science Investments. This financial backing from respected institutions underscores confidence in NADMED's technology and growth potential within the biotechnology landscape.

Positioned at the intersection of innovation and precision, NADMED Ltd. exemplifies a compelling opportunity for venture capitalists looking to invest in groundbreaking solutions in the biotech sector.

Taxonomy: NAD measurement, High-throughput testing, In Vitro Diagnostics, Mitochondrial diseases, Metabolite extraction, NAD metabolism, NAD test kits, Glutathione measurement, Rare diseases, Longevity research, Blood testing equipment, NAD+ research, Laboratory diagnostics

Services & Products

NAD+ and NADH Blood Kits
Laboratory Analysis Services
NAD Metabolite Quantification
Scientific Collaboration and Research Support

Target Customers

Clinical Laboratories Research Institutions Healthcare Providers Biotechnology Companies Pharmaceutical Companies

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 3
Investor
•••• •••• 		01 Aug 2024
Seed •••••• 2
Investor
•••• •••• 		01 Jun 2022
Spinout •••••• 1 •••• •••• 01 Jan 2022

Latest News

View All
Finnis biotech NADMED raises €3.5 million Series A for vitamin B3 deficiencies testing — Eu-startups
Finnis biotech NADMED raises €3.5 million Series A for vitamin B3 deficiencies testing
Eu-startups Aug 22, 2024
Biotech NADMED raises €3.5M series A for 'NAD' vitals testing — Tech
Biotech NADMED raises €3.5M series A for 'NAD' vitals testing
Tech Aug 22, 2024
Finnish biotech NADMED raises €3.5 million Series A for vitamin B3 deficiencies testing — Eu-startups
Finnish biotech NADMED raises €3.5 million Series A for vitamin B3 deficiencies testing
Eu-startups Aug 22, 2024
Biotech scaleup NADMED launches $30K global award to advance innovation in cellular health — Tech
Biotech scaleup NADMED launches $30K global award to advance innovation in cellular health
Tech Dec 02, 2025
Brevo becomes unicorn after a €500M round, Bending Spoons acquires EventBrite, and Europe's biggest... — Tech
Brevo becomes unicorn after a €500M round, Bending Spoons acquires EventBrite, and Europe's biggest H1 edtech deals
Tech Dec 05, 2025

NADMED Ltd. Alternatives & Competitors

View All Alternatives
NADMED Ltd. vs
NADclinic - Trusted Growth Partner and Leading Global Pioneer in NAD+ Therapeutics & Supplementation
NADclinic - Trusted Growth Partner and Leading Global Pioneer in NAD+ Therapeutics & Supplementation United Kingdom

Unlocking the Potential of NAD+ for Cellular Optimisation, Preventative Health & Longevity | Elevati...

21 employees
Health Care
NADMED Ltd. vs
Nuvamid
Nuvamid Switzerland

A clinical stage biotech focused on the research and use of nucleotides, as therapeutics for rare di...

4 employees
Health Care, Manufacturing
NADMED Ltd. vs
Applied BioCode, Inc.
Applied BioCode, Inc. United States

The Ideal Choice for Cost-Effective High Throughput Syndromic Panels

Series Unknown
60 employees
Biotechnology, Health Care
View all alternatives

FAQ About NADMED Ltd.

The standard of NAD measuring.
NADMED Ltd. was founded in 2022.
NADMED Ltd. is headquartered in Finland.
NADMED Ltd. operates in the following industries: Biotechnology.
NADMED Ltd. has approximately 20 employees.
NADMED Ltd. has completed 3 funding rounds, raising a total of $3.50M. The latest funding stage is Seed.
NADMED Ltd. offers: NAD+ and NADH Blood Kits, Laboratory Analysis Services, NAD Metabolite Quantification, Scientific Collaboration and Research Support.
Top alternatives and competitors to NADMED Ltd. include NADclinic - Trusted Growth Partner and Leading Global Pioneer in NAD+ Therapeutics & Supplementation, Nuvamid, Applied BioCode, Inc., Genomadix, Diagonal Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NADMED Ltd. and NADclinic - Trusted Growth Partner and Leading Global Pioneer in NAD+ Therapeutics & Supplementation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NADMED Ltd. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy